# Blood Products Sector

Canonical URL: https://biopharmsignal.com/sector/blood-products

Blood Products includes companies working with plasma-derived proteins, immunoglobulins, clotting factors, and other biologics sourced from blood or plasma. These businesses are often commercial-stage and heavily influenced by manufacturing, collection, and supply-chain execution.

Companies currently grouped under Blood Products: 4

## Recent Sector News

- 2026-05-06 20:05 EST — ADMA — [ADMA Biologics Reports First Quarter 2026 Financial Results and Provides Business Update](https://biopharmsignal.com/news/ADMA/adma-biologics-reports-first-quarter-2026-financial-results-and-provides-business-update) — Source: ADMA Biologics
- 2026-05-04 11:00 EST — ADMA — [ADMA Biologics Announces FDA Approval to Expand the Label for ASCENIV™ to Include Pediatric Immune Compromised Patients Two Years of Age and Older](https://biopharmsignal.com/news/ADMA/adma-biologics-announces-fda-approval-to-expand-the-label-for-ascenivtm-to-include-pediatric-immune-compromised-patients-two-years-of-age-and-older) — Source: ADMA Biologics
- 2026-04-29 11:00 EST — ADMA — [ADMA Biologics to Report First Quarter 2026 Financial Results on May 6, 2026](https://biopharmsignal.com/news/ADMA/adma-biologics-to-report-first-quarter-2026-financial-results-on-may-6-2026) — Source: ADMA Biologics
- 2026-03-27 11:00 EST — ADMA — [ADMA Biologics Issues Statement Refuting Unsubstantiated, Misleading and Inaccurate Allegations by Culper Research](https://biopharmsignal.com/news/ADMA/adma-biologics-issues-statement-refuting-unsubstantiated-misleading-and-inaccurate-allegations-by-culper-research) — Source: ADMA Biologics
- 2026-03-25 10:30 EST — ADMA — [ADMA Biologics Addresses Misleading Short-Seller Report](https://biopharmsignal.com/news/ADMA/adma-biologics-addresses-misleading-short-seller-report) — Source: ADMA Biologics
- 2026-03-02 12:00 EST — ADMA — [ADMA Biologics Announces $125 Million Accelerated Share Repurchase with JPMorgan as Part of a Planned $200 Million 2026 Total Share Repurchase Initiative](https://biopharmsignal.com/news/ADMA/adma-biologics-announces-125-million-accelerated-share-repurchase-with-jpmorgan-as-part-of-a-planned-200-million-2026-total-share-repurchase-initiative) — Source: ADMA Biologics
- 2026-02-25 21:05 EST — ADMA — [ADMA Biologics Reports Record Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update](https://biopharmsignal.com/news/ADMA/adma-biologics-reports-record-fourth-quarter-and-full-year-2025-financial-results-and-provides-business-update) — Source: ADMA Biologics
- 2026-02-18 12:00 EST — ADMA — [ADMA Biologics to Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026](https://biopharmsignal.com/news/ADMA/adma-biologics-to-report-fourth-quarter-and-full-year-2025-financial-results-on-february-25-2026) — Source: ADMA Biologics
- 2026-01-12 13:00 EST — ADMA — [ADMA Biologics Announces Preliminary Full Year 2025 Unaudited Total Revenue and Provides Business Update](https://biopharmsignal.com/news/ADMA/adma-biologics-announces-preliminary-full-year-2025-unaudited-total-revenue-and-provides-business-update) — Source: ADMA Biologics
- 2026-01-05 12:00 EST — ADMA — [ADMA Biologics to Present at the J.P. Morgan Healthcare Conference on January 12, 2026](https://biopharmsignal.com/news/ADMA/adma-biologics-to-present-at-the-j-p-morgan-healthcare-conference-on-january-12-2026) — Source: ADMA Biologics
- 2025-11-05 21:06 EST — ADMA — [ADMA Biologics Announces Third Quarter 2025 Financial Results and Provides Business Update](https://biopharmsignal.com/news/ADMA/adma-biologics-announces-third-quarter-2025-financial-results-and-provides-business-update) — Source: ADMA Biologics

## Companies

- [ADMA](https://biopharmsignal.com/company/ADMA) — ADMA Biologics
- [CERS](https://biopharmsignal.com/company/CERS) — Cerus Corporation
- [GRFS](https://biopharmsignal.com/company/GRFS) — Grifols
- [TAK](https://biopharmsignal.com/company/TAK) — Takeda